nodes	percent_of_prediction	percent_of_DWPC	metapath
Masoprocol—Isoprenaline—MAPK1—head and neck cancer	0.0231	0.823	CrCbGaD
Masoprocol—IGF1R—neck—head and neck cancer	0.0224	0.1	CbGeAlD
Masoprocol—LTB4R—trachea—head and neck cancer	0.0163	0.073	CbGeAlD
Masoprocol—IGF1R—connective tissue—head and neck cancer	0.0161	0.0717	CbGeAlD
Masoprocol—IGF1R—Apoptosis—TNFRSF10B—head and neck cancer	0.0153	0.0204	CbGpPWpGaD
Masoprocol—IGF1R—epithelium—head and neck cancer	0.0153	0.0681	CbGeAlD
Masoprocol—LTB4R—lymphoid tissue—head and neck cancer	0.0142	0.0636	CbGeAlD
Masoprocol—CYP19A1—FSH signaling pathway—AREG—head and neck cancer	0.0134	0.0179	CbGpPWpGaD
Masoprocol—LTB4R—thyroid gland—head and neck cancer	0.0129	0.0577	CbGeAlD
Masoprocol—CYP2J2—parotid gland—head and neck cancer	0.0124	0.0553	CbGeAlD
Masoprocol—IGF1R—lymphoid tissue—head and neck cancer	0.0118	0.0525	CbGeAlD
Masoprocol—LTB4R—G alpha (q) signalling events—KISS1—head and neck cancer	0.0111	0.0149	CbGpPWpGaD
Masoprocol—IGF1R—thyroid gland—head and neck cancer	0.0107	0.0476	CbGeAlD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—KISS1—head and neck cancer	0.00997	0.0133	CbGpPWpGaD
Masoprocol—IGF1R—head—head and neck cancer	0.00947	0.0423	CbGeAlD
Masoprocol—LTB4R—G alpha (q) signalling events—GRP—head and neck cancer	0.00918	0.0123	CbGpPWpGaD
Masoprocol—CYP2J2—trachea—head and neck cancer	0.00915	0.0408	CbGeAlD
Masoprocol—IGF1R—Stabilization and expansion of the E-cadherin adherens junction—CDH1—head and neck cancer	0.00898	0.012	CbGpPWpGaD
Masoprocol—ALOX5—connective tissue—head and neck cancer	0.00858	0.0383	CbGeAlD
Masoprocol—CYP2J2—Tryptophan metabolism—CYP1A1—head and neck cancer	0.0085	0.0114	CbGpPWpGaD
Masoprocol—IGF1R—SHC-related events triggered by IGF1R—MAPK3—head and neck cancer	0.00836	0.0112	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—GRP—head and neck cancer	0.00821	0.011	CbGpPWpGaD
Masoprocol—IGF1R—Posttranslational regulation of adherens junction stability and dissassembly—CDH1—head and neck cancer	0.00807	0.0108	CbGpPWpGaD
Masoprocol—CYP2J2—Arachidonic acid metabolism—GPX1—head and neck cancer	0.00804	0.0107	CbGpPWpGaD
Masoprocol—LTB4R—lymph node—head and neck cancer	0.00803	0.0359	CbGeAlD
Masoprocol—IGF1R—SHC-related events triggered by IGF1R—MAPK1—head and neck cancer	0.00796	0.0106	CbGpPWpGaD
Masoprocol—CYP2J2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.00796	0.0106	CbGpPWpGaD
Masoprocol—ALOX5—Eicosanoid Synthesis—PTGS2—head and neck cancer	0.00759	0.0101	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—KISS1—head and neck cancer	0.00738	0.00987	CbGpPWpGaD
Masoprocol—CYP2J2—thyroid gland—head and neck cancer	0.00724	0.0323	CbGeAlD
Masoprocol—ALOX5—Arachidonic acid metabolism—GPX1—head and neck cancer	0.00716	0.00958	CbGpPWpGaD
Masoprocol—ALOX5—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.00709	0.00948	CbGpPWpGaD
Masoprocol—CYP2J2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00688	0.00919	CbGpPWpGaD
Masoprocol—CYP2J2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00679	0.00907	CbGpPWpGaD
Masoprocol—IGF1R—lymph node—head and neck cancer	0.00663	0.0296	CbGeAlD
Masoprocol—IGF1R—Integrins in angiogenesis—CASP8—head and neck cancer	0.00657	0.00879	CbGpPWpGaD
Masoprocol—CYP2J2—head—head and neck cancer	0.00642	0.0287	CbGeAlD
Masoprocol—IGF1R—SHC-related events triggered by IGF1R—HRAS—head and neck cancer	0.00639	0.00854	CbGpPWpGaD
Masoprocol—IGF1R—Apoptosis—BCL2L1—head and neck cancer	0.00639	0.00854	CbGpPWpGaD
Masoprocol—CYP2J2—Biological oxidations—NAT2—head and neck cancer	0.00632	0.00846	CbGpPWpGaD
Masoprocol—ALOX5—lymphoid tissue—head and neck cancer	0.00628	0.028	CbGeAlD
Masoprocol—CYP2J2—Metapathway biotransformation—NAT2—head and neck cancer	0.00624	0.00834	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—GRP—head and neck cancer	0.00608	0.00813	CbGpPWpGaD
Masoprocol—IGF1R—IGF1 pathway—PIK3CA—head and neck cancer	0.00597	0.00798	CbGpPWpGaD
Masoprocol—CYP19A1—connective tissue—head and neck cancer	0.00594	0.0265	CbGeAlD
Masoprocol—ALOX5—thyroid gland—head and neck cancer	0.0057	0.0254	CbGeAlD
Masoprocol—LTB4R—GPCR ligand binding—KISS1—head and neck cancer	0.00562	0.00752	CbGpPWpGaD
Masoprocol—CYP2J2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00557	0.00745	CbGpPWpGaD
Masoprocol—IGF1R—IGF1 pathway—HRAS—head and neck cancer	0.00552	0.00738	CbGpPWpGaD
Masoprocol—IGF1R—SHP2 signaling—IL2—head and neck cancer	0.00531	0.00709	CbGpPWpGaD
Masoprocol—IGF1R—Stabilization and expansion of the E-cadherin adherens junction—EGFR—head and neck cancer	0.00525	0.00702	CbGpPWpGaD
Masoprocol—IGF1R—Apoptosis—CASP8—head and neck cancer	0.00522	0.00698	CbGpPWpGaD
Masoprocol—ALOX5—head—head and neck cancer	0.00506	0.0226	CbGeAlD
Masoprocol—Isoprenaline—CYP1A1—head and neck cancer	0.00497	0.177	CrCbGaD
Masoprocol—IGF1R—IGF1 pathway—AKT1—head and neck cancer	0.00487	0.00652	CbGpPWpGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—SOD2—head and neck cancer	0.00478	0.00639	CbGpPWpGaD
Masoprocol—CYP2J2—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.00473	0.00633	CbGpPWpGaD
Masoprocol—IGF1R—Posttranslational regulation of adherens junction stability and dissassembly—EGFR—head and neck cancer	0.00472	0.00631	CbGpPWpGaD
Masoprocol—IGF1R—Plasma membrane estrogen receptor signaling—PIK3CA—head and neck cancer	0.00465	0.00622	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—GRP—head and neck cancer	0.00463	0.00619	CbGpPWpGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—GPX1—head and neck cancer	0.00456	0.00609	CbGpPWpGaD
Masoprocol—IGF1R—SHP2 signaling—VEGFA—head and neck cancer	0.00451	0.00603	CbGpPWpGaD
Masoprocol—IGF1R—Apoptosis—BCL2—head and neck cancer	0.00448	0.00599	CbGpPWpGaD
Masoprocol—IGF1R—Plasma membrane estrogen receptor signaling—HRAS—head and neck cancer	0.0043	0.00575	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—XRCC3—head and neck cancer	0.00425	0.00569	CbGpPWpGaD
Masoprocol—IGF1R—Integrins in angiogenesis—VEGFA—head and neck cancer	0.00422	0.00564	CbGpPWpGaD
Masoprocol—ALOX5—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.00422	0.00564	CbGpPWpGaD
Masoprocol—IGF1R—Endochondral Ossification—VEGFA—head and neck cancer	0.00417	0.00557	CbGpPWpGaD
Masoprocol—IGF1R—SHP2 signaling—EGFR—head and neck cancer	0.00406	0.00543	CbGpPWpGaD
Masoprocol—IGF1R—TSH signaling pathway—STAT3—head and neck cancer	0.00403	0.00538	CbGpPWpGaD
Masoprocol—IGF1R—Integrins in angiogenesis—MAPK3—head and neck cancer	0.00399	0.00534	CbGpPWpGaD
Masoprocol—CYP19A1—thyroid gland—head and neck cancer	0.00394	0.0176	CbGeAlD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—CCND1—head and neck cancer	0.00392	0.00524	CbGpPWpGaD
Masoprocol—CYP19A1—Tryptophan metabolism—CYP1A1—head and neck cancer	0.0039	0.00522	CbGpPWpGaD
Masoprocol—IGF1R—TSH signaling pathway—MAPK3—head and neck cancer	0.00385	0.00514	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—PTGS2—head and neck cancer	0.00381	0.0051	CbGpPWpGaD
Masoprocol—IGF1R—Integrins in angiogenesis—MAPK1—head and neck cancer	0.0038	0.00508	CbGpPWpGaD
Masoprocol—IGF1R—Plasma membrane estrogen receptor signaling—AKT1—head and neck cancer	0.0038	0.00508	CbGpPWpGaD
Masoprocol—IGF1R—Posttranslational regulation of adherens junction stability and dissassembly—HRAS—head and neck cancer	0.00379	0.00507	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—PTEN—head and neck cancer	0.00378	0.00506	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—BCL2—head and neck cancer	0.00375	0.00501	CbGpPWpGaD
Masoprocol—IGF1R—TSH signaling pathway—MAPK1—head and neck cancer	0.00366	0.00489	CbGpPWpGaD
Masoprocol—ALOX5—lymph node—head and neck cancer	0.00354	0.0158	CbGeAlD
Masoprocol—LTB4R—Spinal Cord Injury—IL2—head and neck cancer	0.00354	0.00473	CbGpPWpGaD
Masoprocol—IGF1R—SHP2 signaling—PIK3CA—head and neck cancer	0.00352	0.00471	CbGpPWpGaD
Masoprocol—CYP19A1—head—head and neck cancer	0.0035	0.0156	CbGeAlD
Masoprocol—LTB4R—Spinal Cord Injury—CCND1—head and neck cancer	0.00345	0.00461	CbGpPWpGaD
Masoprocol—IGF1R—MicroRNAs in cardiomyocyte hypertrophy—STAT3—head and neck cancer	0.00332	0.00444	CbGpPWpGaD
Masoprocol—IGF1R—Integrins in angiogenesis—PIK3CA—head and neck cancer	0.0033	0.00441	CbGpPWpGaD
Masoprocol—IGF1R—SHP2 signaling—HRAS—head and neck cancer	0.00326	0.00436	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—MAPK3—head and neck cancer	0.00323	0.00432	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—KISS1—head and neck cancer	0.00318	0.00425	CbGpPWpGaD
Masoprocol—IGF1R—TSH signaling pathway—PIK3CA—head and neck cancer	0.00318	0.00425	CbGpPWpGaD
Masoprocol—IGF1R—MicroRNAs in cardiomyocyte hypertrophy—MAPK3—head and neck cancer	0.00317	0.00424	CbGpPWpGaD
Masoprocol—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00316	0.00422	CbGpPWpGaD
Masoprocol—CYP2J2—Biological oxidations—GSTM1—head and neck cancer	0.00312	0.00418	CbGpPWpGaD
Masoprocol—CYP19A1—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00312	0.00417	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—PTEN—head and neck cancer	0.0031	0.00415	CbGpPWpGaD
Masoprocol—CYP2J2—Metapathway biotransformation—GSTM1—head and neck cancer	0.00308	0.00412	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—MAPK1—head and neck cancer	0.00308	0.00411	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—EGFR—head and neck cancer	0.00308	0.00411	CbGpPWpGaD
Masoprocol—IGF1R—IRS-related events triggered by IGF1R—MAPK3—head and neck cancer	0.00303	0.00405	CbGpPWpGaD
Masoprocol—IGF1R—MicroRNAs in cardiomyocyte hypertrophy—MAPK1—head and neck cancer	0.00302	0.00404	CbGpPWpGaD
Masoprocol—CYP2J2—Biological oxidations—CYP1A1—head and neck cancer	0.00296	0.00396	CbGpPWpGaD
Masoprocol—IGF1R—IGF1R signaling cascade—MAPK3—head and neck cancer	0.00295	0.00394	CbGpPWpGaD
Masoprocol—IGF1R—TSH signaling pathway—HRAS—head and neck cancer	0.00294	0.00393	CbGpPWpGaD
Masoprocol—CYP2J2—Metapathway biotransformation—CYP1A1—head and neck cancer	0.00292	0.0039	CbGpPWpGaD
Masoprocol—CYP19A1—Biological oxidations—NAT2—head and neck cancer	0.0029	0.00388	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—KISS1—head and neck cancer	0.00288	0.00386	CbGpPWpGaD
Masoprocol—IGF1R—IRS-related events triggered by IGF1R—MAPK1—head and neck cancer	0.00288	0.00385	CbGpPWpGaD
Masoprocol—CYP19A1—Metapathway biotransformation—NAT2—head and neck cancer	0.00286	0.00383	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—MAPK3—head and neck cancer	0.00284	0.0038	CbGpPWpGaD
Masoprocol—IGF1R—IGF1R signaling cascade—MAPK1—head and neck cancer	0.00281	0.00375	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—MAPK1—head and neck cancer	0.0027	0.00362	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—EGFR—head and neck cancer	0.0027	0.00362	CbGpPWpGaD
Masoprocol—IGF1R—Integrins in angiogenesis—AKT1—head and neck cancer	0.00269	0.0036	CbGpPWpGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—PTGS2—head and neck cancer	0.00268	0.00359	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—RAD51—head and neck cancer	0.00268	0.00359	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—PIK3CA—head and neck cancer	0.00267	0.00357	CbGpPWpGaD
Masoprocol—IGF1R—Endochondral Ossification—AKT1—head and neck cancer	0.00266	0.00356	CbGpPWpGaD
Masoprocol—CYP19A1—FSH signaling pathway—MAPK3—head and neck cancer	0.00265	0.00354	CbGpPWpGaD
Masoprocol—IGF1R—MicroRNAs in cardiomyocyte hypertrophy—PIK3CA—head and neck cancer	0.00262	0.0035	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—GRP—head and neck cancer	0.00262	0.0035	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—UROD—head and neck cancer	0.0026	0.00348	CbGpPWpGaD
Masoprocol—IGF1R—TSH signaling pathway—AKT1—head and neck cancer	0.00259	0.00347	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—TP53—head and neck cancer	0.00258	0.00345	CbGpPWpGaD
Masoprocol—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00256	0.00342	CbGpPWpGaD
Masoprocol—IGF1R—Apoptosis—TP53—head and neck cancer	0.00253	0.00339	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—MAPK1—head and neck cancer	0.00252	0.00338	CbGpPWpGaD
Masoprocol—CYP19A1—FSH signaling pathway—MAPK1—head and neck cancer	0.00252	0.00337	CbGpPWpGaD
Masoprocol—IGF1R—IRS-related events triggered by IGF1R—PIK3CA—head and neck cancer	0.0025	0.00334	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—HRAS—head and neck cancer	0.00247	0.0033	CbGpPWpGaD
Masoprocol—CYP19A1—lymph node—head and neck cancer	0.00245	0.0109	CbGeAlD
Masoprocol—IGF1R—IGF1R signaling cascade—PIK3CA—head and neck cancer	0.00243	0.00326	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—GRP—head and neck cancer	0.00238	0.00318	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—BCL2—head and neck cancer	0.00233	0.00312	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—UROD—head and neck cancer	0.00232	0.0031	CbGpPWpGaD
Masoprocol—IGF1R—IRS-related events triggered by IGF1R—HRAS—head and neck cancer	0.00231	0.00309	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—TP53—head and neck cancer	0.00227	0.00304	CbGpPWpGaD
Masoprocol—IGF1R—IGF1R signaling cascade—HRAS—head and neck cancer	0.00225	0.00301	CbGpPWpGaD
Masoprocol—IGF1R—Insulin Signaling—PTEN—head and neck cancer	0.00222	0.00296	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—AKT1—head and neck cancer	0.00218	0.00292	CbGpPWpGaD
Masoprocol—IGF1R—Apoptosis—AKT1—head and neck cancer	0.00214	0.00286	CbGpPWpGaD
Masoprocol—IGF1R—MicroRNAs in cardiomyocyte hypertrophy—AKT1—head and neck cancer	0.00214	0.00286	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—TP53—head and neck cancer	0.00212	0.00283	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—HRAS—head and neck cancer	0.00203	0.00271	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.00202	0.0027	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—CCND1—head and neck cancer	0.002	0.00268	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—PTEN—head and neck cancer	0.00193	0.00258	CbGpPWpGaD
Masoprocol—IGF1R—Insulin Signaling—MAPK3—head and neck cancer	0.00189	0.00253	CbGpPWpGaD
Masoprocol—IGF1R—Insulin Signaling—MAPK1—head and neck cancer	0.0018	0.00241	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.0018	0.00241	CbGpPWpGaD
Masoprocol—CYP19A1—FSH signaling pathway—AKT1—head and neck cancer	0.00179	0.00239	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—head and neck cancer	0.00176	0.00235	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—VEGFA—head and neck cancer	0.00175	0.00233	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—KISS1—head and neck cancer	0.0017	0.00228	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—head and neck cancer	0.00167	0.00224	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—head and neck cancer	0.00167	0.00224	CbGpPWpGaD
Masoprocol—LTB4R—G alpha (q) signalling events—PIK3CA—head and neck cancer	0.00162	0.00217	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—MAPK1—head and neck cancer	0.00157	0.0021	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—EGFR—head and neck cancer	0.00157	0.0021	CbGpPWpGaD
Masoprocol—IGF1R—Insulin Signaling—PIK3CA—head and neck cancer	0.00156	0.00209	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	0.00145	0.00194	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—KISS1—head and neck cancer	0.00145	0.00194	CbGpPWpGaD
Masoprocol—IGF1R—Insulin Signaling—HRAS—head and neck cancer	0.00145	0.00193	CbGpPWpGaD
Masoprocol—CYP19A1—Biological oxidations—GSTM1—head and neck cancer	0.00143	0.00192	CbGpPWpGaD
Masoprocol—CYP19A1—Metapathway biotransformation—GSTM1—head and neck cancer	0.00141	0.00189	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—GRP—head and neck cancer	0.0014	0.00188	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—PIK3CA—head and neck cancer	0.00136	0.00182	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—STAT6—head and neck cancer	0.00136	0.00182	CbGpPWpGaD
Masoprocol—CYP19A1—Biological oxidations—CYP1A1—head and neck cancer	0.00136	0.00182	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	0.00134	0.0018	CbGpPWpGaD
Masoprocol—CYP19A1—Metapathway biotransformation—CYP1A1—head and neck cancer	0.00134	0.00179	CbGpPWpGaD
Masoprocol—IGF1R—Insulin Signaling—AKT1—head and neck cancer	0.00128	0.00171	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—HRAS—head and neck cancer	0.00126	0.00169	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—YAP1—head and neck cancer	0.00121	0.00161	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—UROD—head and neck cancer	0.0012	0.0016	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—GRP—head and neck cancer	0.00119	0.0016	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—STAT6—head and neck cancer	0.00116	0.00155	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.00115	0.00154	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.00114	0.00152	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—AKT1—head and neck cancer	0.00111	0.00149	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—CASP8—head and neck cancer	0.0011	0.00147	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—CDH1—head and neck cancer	0.00109	0.00145	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—NAT2—head and neck cancer	0.00108	0.00145	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—YAP1—head and neck cancer	0.00103	0.00137	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.00102	0.00137	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.00101	0.00136	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—NAT2—head and neck cancer	0.000964	0.00129	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—DPYD—head and neck cancer	0.000948	0.00127	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—BCL2—head and neck cancer	0.000945	0.00126	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000928	0.00124	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—YAP1—head and neck cancer	0.0009	0.0012	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—DPYD—head and neck cancer	0.000845	0.00113	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—CCND1—head and neck cancer	0.000811	0.00108	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—YAP1—head and neck cancer	0.000802	0.00107	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—PTEN—head and neck cancer	0.000782	0.00105	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—head and neck cancer	0.000707	0.000945	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—IL2—head and neck cancer	0.000697	0.000932	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000676	0.000904	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—head and neck cancer	0.000636	0.000851	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—EGFR—head and neck cancer	0.000636	0.00085	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—IL2—head and neck cancer	0.000633	0.000846	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000603	0.000806	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.00059	0.000788	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NOTCH1—head and neck cancer	0.000543	0.000727	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—TYMS—head and neck cancer	0.00054	0.000723	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GSTM1—head and neck cancer	0.000534	0.000714	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—TP53—head and neck cancer	0.000534	0.000714	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000527	0.000705	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000526	0.000703	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000522	0.000698	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GPX1—head and neck cancer	0.000512	0.000684	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—MAPK3—head and neck cancer	0.000509	0.000681	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CYP1A1—head and neck cancer	0.000506	0.000677	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—NAT2—head and neck cancer	0.000497	0.000664	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—MAPK1—head and neck cancer	0.000484	0.000647	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—EGFR—head and neck cancer	0.000484	0.000647	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—TYMS—head and neck cancer	0.000482	0.000644	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GSTM1—head and neck cancer	0.000476	0.000637	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—PIK3CA—head and neck cancer	0.000463	0.000619	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NOTCH1—head and neck cancer	0.000462	0.000618	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GPX1—head and neck cancer	0.000456	0.00061	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CYP1A1—head and neck cancer	0.000451	0.000603	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	0.000451	0.000603	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—DPYD—head and neck cancer	0.000435	0.000582	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—PIK3CA—head and neck cancer	0.00042	0.000562	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000416	0.000556	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—YAP1—head and neck cancer	0.000413	0.000553	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—HRAS—head and neck cancer	0.000389	0.00052	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—AKT1—head and neck cancer	0.000378	0.000505	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IL2—head and neck cancer	0.000374	0.0005	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000371	0.000496	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CCND1—head and neck cancer	0.000365	0.000487	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PTEN—head and neck cancer	0.000352	0.00047	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—AKT1—head and neck cancer	0.000343	0.000459	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IL2—head and neck cancer	0.000318	0.000425	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—VEGFA—head and neck cancer	0.000318	0.000425	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—STAT3—head and neck cancer	0.000315	0.000421	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.00031	0.000415	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CCND1—head and neck cancer	0.00031	0.000414	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PTGS2—head and neck cancer	0.000301	0.000403	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MAPK3—head and neck cancer	0.000301	0.000402	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PTEN—head and neck cancer	0.000299	0.0004	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MAPK1—head and neck cancer	0.000286	0.000382	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—EGFR—head and neck cancer	0.000286	0.000382	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000271	0.000362	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—VEGFA—head and neck cancer	0.00027	0.000361	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PTGS2—head and neck cancer	0.000268	0.000359	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—STAT3—head and neck cancer	0.000268	0.000358	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PTEN—head and neck cancer	0.000263	0.000351	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MAPK3—head and neck cancer	0.000256	0.000342	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PIK3CA—head and neck cancer	0.000248	0.000332	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—TYMS—head and neck cancer	0.000248	0.000332	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GSTM1—head and neck cancer	0.000245	0.000328	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MAPK1—head and neck cancer	0.000243	0.000325	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—EGFR—head and neck cancer	0.000243	0.000325	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—TP53—head and neck cancer	0.00024	0.000321	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GPX1—head and neck cancer	0.000235	0.000314	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PTEN—head and neck cancer	0.000234	0.000313	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYP1A1—head and neck cancer	0.000232	0.000311	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—HRAS—head and neck cancer	0.00023	0.000307	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PIK3CA—head and neck cancer	0.000211	0.000282	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TP53—head and neck cancer	0.000204	0.000273	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—AKT1—head and neck cancer	0.000203	0.000271	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—HRAS—head and neck cancer	0.000195	0.000261	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000191	0.000255	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PIK3CA—head and neck cancer	0.000185	0.000248	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—AKT1—head and neck cancer	0.000172	0.000231	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PIK3CA—head and neck cancer	0.000165	0.000221	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—AKT1—head and neck cancer	0.000151	0.000202	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PTGS2—head and neck cancer	0.000138	0.000185	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—AKT1—head and neck cancer	0.000135	0.00018	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PTEN—head and neck cancer	0.000121	0.000161	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PIK3CA—head and neck cancer	8.51e-05	0.000114	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—AKT1—head and neck cancer	6.95e-05	9.29e-05	CbGpPWpGaD
